Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

BACKGROUND: The purpose of this study was to evaluate the long-term cost-effectiveness (including hospitalizations and cardiometabolic consequences) of atypical antipsychotics among adults with schizophrenia. METHODS: A 5-year Markov cohort cost-effectiveness model, from a US payer perspective, was...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Day, Ken, Rajagopalan, Krithika, Meyer, Kellie, Pikalov, Andrei, Loebel, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775636/
https://www.ncbi.nlm.nih.gov/pubmed/24049452
http://dx.doi.org/10.2147/CEOR.S47990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775636/
https://www.ncbi.nlm.nih.gov/pubmed/24049452
http://dx.doi.org/10.2147/CEOR.S47990

Ejemplares similares